valproic acid has been researched along with Heart Disease, Ischemic in 4 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Svennerholm, K | 1 |
Bergh, N | 1 |
Larsson, P | 1 |
Jern, S | 1 |
Johansson, G | 1 |
Biber, B | 1 |
Haney, M | 1 |
Kuai, Q | 1 |
Wang, C | 1 |
Wang, Y | 2 |
Li, W | 1 |
Zhang, G | 1 |
Qiao, Z | 1 |
He, M | 1 |
Wang, X | 1 |
Jiang, X | 1 |
Su, L | 1 |
He, Y | 1 |
Ren, S | 1 |
Yu, Q | 1 |
Ferrari, R | 1 |
Merli, E | 1 |
Cicchitelli, G | 1 |
Mele, D | 1 |
Fucili, A | 1 |
Ceconi, C | 1 |
Meerson, FZ | 1 |
Gimrikh, EO | 1 |
Gutsol, LIa | 1 |
Popov, SV | 1 |
Plekhanov, IG | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina[NCT03696940] | Phase 3 | 120 participants (Actual) | Interventional | 2018-05-28 | Active, not recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for valproic acid and Heart Disease, Ischemic
Article | Year |
---|---|
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
Topics: Cardiotonic Agents; Cardiovascular Diseases; Carnitine; Humans; Kidney Failure, Chronic; Liver; Myoc | 2004 |
3 other studies available for valproic acid and Heart Disease, Ischemic
Article | Year |
---|---|
Histone deacetylase inhibitor treatment increases coronary t-PA release in a porcine ischemia model.
Topics: Animals; Disease Models, Animal; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Myocardial Isc | 2014 |
Energy metabolism regulated by HDAC inhibitor attenuates cardiac injury in hemorrhagic rat model.
Topics: Animals; Cell Line; Disease Models, Animal; Energy Metabolism; Hemorrhage; Histone Deacetylase Inhib | 2016 |
[The anti-arrhythmic efficacy of sodium valproate].
Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Evaluation; Electrocar | 1992 |